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1. Introduction  
Clinical imaging exists for the noninvasive, in vivo study of disease in the body. Modalities 
such as computed tomography (CT) and magnetic resonance imaging (MRI) do this by 
providing information about patient anatomy, so physicians can identify physical 
abnormalities in the tissue morphology. In contrast, molecular imaging modalities like 
positron emission tomography (PET) do not describe the anatomy directly, but rather track 
specific biological processes. This enables the investigation of bodily function, allowing the 
identification of abnormalities in tissue physiology. 
Central to molecular imaging is the molecule, or more specifically, the radiopharmaceutical. 
PET is used to study many processes including blood flow, tissue perfusion, neurological 
function, cellular proliferation, and tumor metabolism, and each application uses a unique 
radiotracer that has been engineered to track a specific molecule or biochemical process. For 
example, the most common radiopharmaceutical used in PET today is 2-deoxy-2-(18F)fluoro-
D-glucose or 18F-FDG. In this tracer, 18F (a radioactive isotope of Fluorine) is substituted in 
place of the 2' hydroxyl group in the glucose molecule. FDG is chemically similar to glucose, 
and so it begins to follow the same metabolic pathway. The accumulation of FDG is 
subsequently used as an index of tissue metabolism. PET forms an image by measuring 
(estimating) the spatiotemporal distribution of the biomarker. 
Information about cellular metabolism proves especially useful in oncology, as rapidly 
growing tumors have increased energy demands. (Warburg, Posener et al. 1931)  In the 
clinical setting, PET provides physicians with a standardized tool for the assessment, 
diagnosis, and treatment planning of neoplastic diseases. Many developments have 
facilitated its integration into the clinic, but few as rapidly as the addition of the CT 
modality, and now the hybrid PET/CT. 
In modern PET/CT, the CT transmission scan is integral to important calculations in the 
processing of the PET data. Additionally, this configuration provides information about 
anatomy as well as physiology. The influence of the combined modality provides an 
unsurpassed level of patient care. Physicians are able to better diagnose disease and plan 
and monitor response to treatment more effectively. 
2. Background  
Before exploring the benefit of adding CT to PET, it is worthwhile to review some basic 
principles of positron emission tomography. As expected, PET scanners measure the energy 
released as the result of a positron emission. When an unstable isotope randomly decays, it 
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can do so in a number of ways. In the case of proton-heavy isotopes like Fluorine-18, the 
process is positive beta (β+) decay,1 where a proton is converted into a neutron, emitting a 
positron and neutrino. 
The positron is the anti-matter counterpart of the electron, namely it has the same mass and 
spin as the electron, but with the opposite charge. When the ejected positron encounters a 
nearby electron, the pair self-annihilates, and is converted to pure energy according to 
Einstein’s theory of relativity. This energy is released as two 511keV (the rest mass of the 
electron and positron) photons, propagating in opposite directions, thus conserving 
momentum.2 
The fundamental job of the PET tomograph is to detect these annihilation photons and 
identify pairs arising from the same event. Modern PET scanners consist of multiple rings of 
detectors and use a detection acceptance timing window of a few nanoseconds, enough time 
needed for a photon to traverse the full  diameter of the transaxial field of view (FOV). 
When a photon is detected, the timing window is triggered. If another photon is detected 
within this window, the two are assumed to be from the same annihilation and are 
registered as a prompt event. The imaginary line connecting the two detectors, along which 
the event occurred, is termed the line-of-response (LOR) and is recorded for each prompt.  
If a second photon is not detected within the timing window, the original detected photon is 
recorded as a single event and does not have an LOR associated with it. The singles rate is 
typically a few orders of magnitude greater than the prompts. Additionally, multiple 
photons can hit the detectors within the timing window, giving rise to multiple events. 
These are rejected since no LOR can be assigned. 
In a routine scan, millions of prompt events are recorded each second, and each LOR has its 
own prompt count-rate frequency. This frequency is directly related to the total activity 
contained within a ‘tube’ connecting the detector faces along the LOR. Thus, PET is a 
quantitative tool, in that it is possible to measure the activity concentration in a small unit 
volume in an absolute sense. However, it is important to remember that a PET scanner does 
not measure the activity distribution directly, but only as linear sums through the distribution, 
meaning some information is lost. The acquisition data are grouped as sums along parallel 
LORs, which define angular ‘projections’, which are then arranged in rows for each successive 
angle to form sinograms. The estimation of the original object from this projection data is a 
daunting task that receives ever-increasing attention. (Barrett and Myers 2004)   
3. Gantry design  
A modern PET scanner consists of a horizontal bed which passes through a circular bore 
encasing multiple rings of detectors. The port diameter size of a typical gantry is 70-80 cm 
with an axial field of view (FOV) around 20 cm. The subject is positioned appropriately, and 
each bed position is scanned for 2-3 minutes.3  
                                                 
1 F-18 has a branching fraction of 0.97 which means there is a 3% chance that it will decay via electron 
capture, (Shapiro 2002) where an innermost orbital electron combines with a nuclear proton to create a 
nuclear neutron, releasing only a neutrino.  
2 The relative alignment of the initial particle spins and the positron’s kinetic energy at the time of 
annihilation may affect the number and direction of the emitted photons; however, these effects are 
usually considered negligible in practice. (Valk 2003) 
3 A routine whole-body scan (from the cranial orbits to mid-thigh) typically includes 4-6 bed positions. 
Melanoma scans of the entire body use as many as twelve. 
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Today’s PET detection systems are scintillation-based; once a 511keV photon strikes a 
detector crystal, it is converted into light. This light is collected by a system of coupled 
photomultiplier tubes (PMTs), which then output an electrical pulse. 4  The strength of this 
pulse determines the initial energy deposited in the crystal and can be used to reject (scatter) 
events that do not satisfy the energy threshold. The Biograph TruePoint TrueV PET/CT 
scanner (Siemens Molecular Imaging) employs four rings of 48 detector blocks, each 
containing an array of 13 x 13 crystals. (Jakoby, Bercier et al.) 
The first PET/CT images came from individual systems operated independently from each 
other. The CT data was manipulated for use in the PET corrections, and the images were 
registered manually. Modern tomographs contain the PET and CT components within the 
same gantry, separated by 80 cm axially. (Townsend, Beyer et al. 2003)  Software now 
automates both acquisition processes, as well as data correction, reconstruction, and co-
registration of the final images. (Barrett and Myers 2004)   
 
 
Fig. 1. Schematic diagram of early PET/CT concept. Centers of fields-of-view of PET and CT 
are 60 cm apart. Combined PET/CT gantry is 110 cm deep, 170 cm high, and 168 cm wide. 
(Beyer, Townsend et al. 2000) 
4. PET Errors  
Most reconstruction algorithms treat the data as if they are free of noise or error, but in 
reality, the PET acquisition process is far from perfect. There are many physical effects that 
can corrupt the integrity of the data, including photon attenuation, random registration, 
scattered coincidences, varying detector sensitivity profiles, and gantry geometry. These 
errors degrade image quality by adding noise to the PET data and must typically be 
corrected prior to reconstruction for accurate image quantization. It is common in modern 
PET to perform these data corrections based on large-scale, statistical models of these effects. 
Every registered prompt event is not the result of a true coincident pair of photons. In fact, 
each acquired prompt can belong to one of three groups, trues, randoms or scatter. Both 
randoms and scatter cause the system to associate incorrect LORs to their events and 
therefore must be corrected.  
                                                 
4 The PMTs are arranged in a light-sharing configuration (four PMTs per detector block) to reduce cost 
and packing fraction. (Casey and Nutt 1986)   
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4.1 Randoms  
Random coincidences happen when two photons from different events randomly hit two 
detectors within the same timing window. These events contain no useful information about 
the tracer distribution and, because they are random in nature, add smooth background 
noise to the data. The random coincidence rate is related to the size of the timing window 
and the singles rates on the detectors.  
A few methods have been proposed to model the randoms distribution, including detector 
singles-based calculations and tail-fitted, Gaussian estimations. (Valk 2003)  Currently 
however, the most commonly implemented technique is the delayed channel method. Here, 
a timing window is delayed (a few times the timing window length) to acquire a duplicate 
data stream in parallel to the prompts. The delayed timing window guarantees that any 
recorded coincident photon pair did not belong to the same annihilation event. These 
delayed data provide accurate representation of the prompt randoms rate and can usually 
be stored independently, allowing post-processing the randoms data to reduce noise.  
4.2 Scatter  
Scattered events occur when at least one photon of the coincident pair is Compton scattered, 
deflecting it before hitting the detector ring. Scattering decreases the energy of a photon, so 
this effect is addressed by acquiring only the photons lying within the photopeak energies. 
This is accomplished with an appropriate energy-acceptance window (typically 450-650 keV 
for LSO-based scanners). However, a photon can scatter through a relatively large angle and 
still have enough energy to be accepted, so many scattered events are not rejected by the 
energy discriminator. These prompt scatter events are generally treated as a nuisance to the 
data which should be removed.  
In the early years of PET, 2D acquisition was commonly used; disks of lead shielding were 
positioned between each detector ring to “shadow” the activity arising outside of the direct 
plane. This decreased the number of randoms and scatter events and simplified the 
reconstruction process. Now however, 3D, or septaless, acquisition has almost completely 
replaced its 2D counterpart, due to its increased sensitivity. This change was due to 
sophisticated correction methods and faster reconstruction algorithms. 
Many techniques have been developed to handle scatter correction. Empirical schemes have 
been used that measure auxiliary data, such as the coincidence rates below 511keV, under 
the assumption that these lower energy photons must be the result of scattering. By 
employing multiple energy windows, this auxiliary data is scaled and subtracted from the 
data in the photopeak window. (Grootoonk, Spinks et al. 1996)  Scatter correction based on 
multiple energy measurements has the advantage of accounting for scatter arising from 
activity outside of the field of view. However, the auxiliary data are noisy and their 
processing requires more computing power. Another technique is to estimate the scatter 
distribution from prompt counts registered at places known to contain no activity. Scatter 
has a low frequency, broad distribution with tails that extend beyond the boundaries of the 
object. These tails can be used to fit a smooth Gaussian function to the scatter distribution. 
(Stearns 1995)  This model performs reasonably well in brain studies, but can lead to errors 
in whole-body scans where the thorax occupies a larger portion of the FOV, resulting in 
relatively small scatter tails to fit. 
Some approaches used in 2D PET (with inter-ring septa) are convolution-based integral 
transformations of the projections. (Bergström, Eriksson et al. 1983)  In this method, the scatter 
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distribution is estimated through the convolution of a spatially dependent scatter “kernel” 
with the linear projections of the prompt photopeak data. The resulting distribution profiles 
are then subtracted from the projections to yield scatter-free estimates of the data. It works 
well in regions of relatively homogeneous density like the brain. This method was developed 
for 2D PET but has been extended to 3D systems. (Bailey and Meikle 1994)   
Modern 3D PET algorithms, however, most commonly use theoretical simulation techniques 
to correct for scatter. They are arguably the most accurate scatter corrections, in that they 
attempt to realistically simulate the scattering process. Scatter simulations model the 
distribution based on the underlying physics of Compton scattering. With an initial estimate 
of the emitter distribution and a coefficient map of the attenuating material, Klein-Nishina 
calculations are used to accurately compute the scatter distribution. (Ollinger 1996)  
4.3 Attenuation  
In addition to the noise in the prompt counts, PET data is also degraded by other effects 
including attenuation. Compton scattering (in combination with photoelectric absorption) 
contributes to photon attenuation along each LOR. It is directly related to the amount of 
matter (tissue) lying in the small tube centered along the LOR, so attenuation is a bigger 
problem in larger patients.  
This loss of count data results in reduced image contrast and detail for internal features, 
especially those lying deep inside the subject. For a given scan, any volume contains a finite 
amount of attenuating material, and a coefficient of total linear attenuation can thus be 
associated to each LOR. These coefficients are ordered and arranged in sinograms, similar to 
the PET projections, to yield an attenuation coefficient factor (ACF) map. In the simplest sense, 
attenuation correction is the multiplication of the PET projection data with the ACF map.  
Before the introduction of hybrid PET/CT, ACF maps were generated using a 511keV 
photon transmission scan of the subject prior to the emission measurement. This typically 
involved rotating a line source of annihilation photons (usually 68Ge) around the patient to 
provide information about tissue density. Sinogram windowing and data from the 
subsequent emission measurement were used to remove most of the emission counts from 
the transmission data. Furthermore, FDG studies have relatively low count rates, and there 
is little increase in noise in the correction due to emission activity. (Carson, Daube-
Witherspoon et al. 1988)  These methods produced accurate ACF maps, but required 
increased patient time in the scanner.  
4.4 Normalization  
Reconstruction algorithms generally assume the same sensitivity for all LORs, but this is not 
the case. Differences in crystal elements and photomultiplier tubes, as well as scanner 
geometry and detector block gaps, all contribute to varying sensitivities for different LORs. 
As a result, quality control must be performed regularly to assure that the PET scanner is 
operating optimally and that the sensitivity profiles are known for all LOR projections. This 
is usually accomplished by scanning a uniform source; since all LORs are illuminated by the 
same activity concentration, they should yield consistent projections.  The (inverse of the) 
projection data is used to calculate the normalization, i.e. those with higher relative 
sensitivity appear hotter and will be weighted less in the routine clinical reconstructions. 
Noisy data is not the only drawback to emission tomography. With regards to spatial 
resolution, nuclear imaging modalities are inferior to conventional anatomical imaging. For 
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example, a typical PET image has an average spatial resolution of 4 mm but that of a typical 
CT image can be 0.5 mm. This is due to many factors, including the finite size of detector 
elements, positron range, Compton scatter, and photon non-collinearity. 
PET is a complex procedure that is susceptible to many errors. Compared to most other 
imaging modalities, emission tomography is a relatively noisy process; the amount of 
available data is fundamentally count-limited by the ethically allowed dose of the 
radiotracer and convenient patient time inside the scanner. Furthermore, the acquired data 
are degraded by the many physical distortions previously mentioned. Modern correction 
techniques are very sophisticated and evolved through innovations in technology and 
methodology. One of the most significant of these developments was the addition of CT to 
the PET system.  
5. Hybrid PET/CT  
The PET/CT scanner, invented by Dr. Ron Nutt and Dr. David Townsend, was originally 
built at the University of Pittsburgh in 1998. (Townsend, Beyer et al. 1998)  CT-based PET 
corrections had been investigated (Beyer, Kinahan et al. 1994) and the idea to co-register 
images from different modalities had been proposed for brain studies, (Pelizzari, Chen et al. 
1989; Pietrzyk, Herholz et al. 1996) but the hybrid prototype was the first time multiple 
medical imaging modalities had been combined into a single gantry. This new tool offered 
improved clinical diagnoses and patient management; it also increased patient comfort and 
scanner throughput. (Kluetz, Meltzer et al. 2000)  The PET/CT scanner was named 
invention of the year in 2000 by Time Magazine.  
5.1 Attenuation  
In the past, the data for the PET attenuation correction came from a 10-15 min 511keV 
transmission scan that was usually administered for each bed position, prior to the emission 
scan. With the combination of PET and CT, it was possible to generate an ACF map using 
the CT transmission scan.  It is no longer necessary to include PET transmission components 
with the scanners, eliminating their initial costs as well as those associated with the periodic 
replacement of decayed sources. The high flux of X-rays leads to lower statistical noise in 
the ACF measurement and shorter transmission scan leaves longer times for emission scan, 
further lowering statistical noise for the total scan duration.  
The attenuation coefficients are not constant between CT and PET energies. Attenuation is a 
combination of photon scatter and absorption, and the ratio of these effects is not necessarily 
the same for different photon energies and material densities. The ACFs found at CT 
energies, from 40-140 keV, (Shreve and Townsend 2008) require scaling if they are to be 
used to correct emission data at the 511keV PET energy.  
It has been shown that linear scaling methods produce proper ACFs when Compton 
interactions dominate the attenuation. However they yield poor estimates when 
photoelectric contributions dominate, as they do at lower CT energies, especially in high-
density regions like bone. (Kinahan, Townsend et al. 1998)  Thus, accurate attenuation 
coefficients cannot be rigorously estimated through simple linear scaling. For this reason, 
density segmentation of different tissue regions has been used successfully, but, just as 
linear scaling methods have errors caused by the different ratio of attenuation coefficients 
for bone, segmentation methods produce errors in regions where there are variations in 
density, such as the lung. (Beyer, Kinahan et al. 1994)   
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CT-based PET attenuation factors are typically computed through a hybrid combination of 
both methods. The ratios of attenuation coefficients at CT and PET energies are roughly 
equal for all tissue except bone (Hubbell and Standards 1969), so current methods segment 
regions above 300 Hounsfield units as bone tissue and below 300 as soft tissue, respectively. 
The respective CT-to-PET ACF scaling is 2.26 and 1.90. (Shreve and Townsend 2008)  This 
bi-linear scaling has shown excellent results that perform superior to 511keV transmission 
methods with lower noise. (Kinahan, Townsend et al. 1998)  
5.2 Scatter  
Scatter is a major problem in 3D PET (Cherry, Dahlbom et al. 1991); a 511 keV photon 
traveling in water (or human tissue) has a 50% chance of being scattered by an electron. 
Consequently, in a clinical scan, 40-60% of the data may be from scattered photon events. 
Today, the most commonly used correction methods in quantitative clinical 3D PET are 
based on scatter simulations, which require a coefficient map of the attenuation to 
realistically model the scattering process. The 511keV ACF scaled from the CT transmission 
scan is an excellent source of this information.  
Monte Carlo simulation is widely used to model scatter and provides the most complete 
realization of the physical effects associated with it. This technique is used for both 
evaluation and for the correction itself, but it is currently too slow to be used clinically and is 
limited to research applications. Instead of accounting for all scattering interactions, the 
model can be simplified by considering only single scatter events, i.e. events where just one 
photon of the pair is scattered only once. (Watson, Newport et al. 1996) This simplification is 
reasonable since it has been shown that 75-80% of scattered coincidences are due to these 
single scatter events. (Barney, Rogers et al. 1991)  It is further justified by the fact that 
multiple scatter has little effect on the total distribution. 
The single scatter simulation (SSS) calculation relies on a volume integral of a scattering 
kernel over the body, using the relationship between an initial estimate of the activity 
distribution volume,5 the reconstructed attenuation volume, and Compton scattering cross-
sections calculated from the Klein-Nishina formula. The scatter contribution is calculated for 
every LOR across all possible scattering points in the FOV. A faster method has been proposed 
that is better suited to clinical application. (Watson 2000)  With this method, fewer LORs are 
used in the calculation and continuity is replaced by discrete sampling of the volume data. The 
sample points are relative to the transaxial FOV (not the patient) and, since the scatter 
distribution is relatively smooth, the sampling can be fairly coarse (around 2 cm) without 
much loss of accuracy. This coarse-scatter sinogram is then interpolated to account for the 
missing data. Speed is further improved by reusing computed ray sums through the object 
since scatter calculations in multiple LORs may involve the same photon travel paths. 
(Mumcuoglu, Leahy et al. 1996)  Accuracy is further improved by iterating the scatter 
calculation, i.e. with each iteration, the previously corrected emission is used in the calculation.  
5.3 Reconstruction  
In addition to data corrections, the CT information is used in the actual reconstruction 
process. Modern reconstruction algorithms do not produce images by directly inverting the 
                                                 
5 different methods have been employed for initial estimates of the emission volume distribution; 
Watson et al. used 3d reconstructions of the projection data, which include scatter. (Watson, Newport et 
al. 1996) 
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projection data, as they did in the past. Instead, they are based on sequential, iterative 
estimates that converge to an image that best represents the original object. These 
algorithms are termed expectation maximization (EM) and are well suited to emission 
tomography because they are less sensitive to noise in the data. 
Iterative reconstruction involves the forward and back-projection of simulated data in the 
attempt to match the measured data as closely as possible. Integral to this method is the 
system matrix which models the characteristics of the scanning process. It essentially defines 
the individual probabilities that each projection bin contributes to each image pixel, and vice 
versa. Ideally, the system matrix accounts for all physical effects of scanner geometry and 
performance. Attenuation-weighted (AW) algorithms incorporate the attenuation map from 
the CT scan into the system matrix, and the forward projector is better able to realistically 
simulate the acquisition process. This increases the accuracy of the physical model unique to 
the individual scan. 
CT data can also be used in the reconstruction scheme as prior information. Prior 
distributions are sometimes used to regularize the algorithm, enforcing smoothness in the 
image. Images with high frequency noise (large differences between neighboring pixels) are 
assigned a lower probability, i.e. they are penalized by the prior. The CT image can be used 
to segment the image into regions in which uniform tracer concentration is expected. These 
segmented boundaries are incorporated in a prior so that smoothness is only imposed in 
regions belonging to the same anatomical region. The use of anatomical images as prior 
information in maximum a posteriori (MAP) reconstructions has yielded improved 
reconstructions in mathematical phantom simulations. (Gindi, Lee et al. 1991)  However this 
approach is typically not used clinically since anatomical information is readily available to 
be visually interpreted in the fused images.  
6. Clinical impact  
PET/CT has revolutionized healthcare, and it continues to expand its utility to a wide array 
of applications. This is illustrated by the growing number of world-wide scanner sales. In 
2002, only a couple years after its introduction, PET/CT systems accounted for nearly half of 
the total PET scanner sales, with the other half belonging to that of dedicated PET scanners. 
By 2005, PET/CT systems had almost completely overtaken the market. Today, nearly all 
commercial systems are PET/CT. 
The first PET scans were conducted in the 70’s at Washington University in St. Louis by 
Michael Phelps, et al. (Phelps, Hoffman et al. 1975; Phelps, Hoffman et al. 1976)  With the 
development of FDG later that decade, PET gained more attention for its potential clinical 
value; but due to the difficulties of the imaging process and the high costs of the 
radiopharmaceuticals, PET was strictly used for research. However, as more PET studies 
were performed, its clinical utility began to emerge, specifically in the evaluation of 
disorders of the heart and brain. This led to the first reimbursement of PET in 1995, for 
myocardial perfusion imaging using Rubidium-82. (Workman and Coleman 2006)  The first 
Medicare reimbursement of FDG-PET scans in oncology came in January of 1998 for the 
initial staging of non small-cell lung cancer and the characterization of single pulmonary 
nodules. (Bietendorf 2004)  Coverage for colorectal cancer, lymphoma, melanoma, and many 
others followed in the next few years.  
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Fig. 2. Transaxial PET, CT, and fused images taken from a 68 year-old male diagnosed with 
cholangiocarcinoma. The combined modality provides physiological information as well as 
anatomical location. The disease is not obvious in the CT image alone but the PET scan 
shows an intense focus of metabolic activity medial to the hepatic caudate lobe likely 
compatible with recurrent malignancy. 
 
   
Fig. 3. Transaxial PET, CT, and fused images of a 40 year-old female with a history of heavy 
smoking. The intense metabolic uptake illustrated by the PET scan is accompanied by a 2.2 x 
2.8 cm upper lobe mass on the CT image, which was later diagnosed as non-small cell 
carcinoma.  
Today, Medicare provides reimbursement of PET for the diagnoses and monitoring of nearly 
every form of cancer. Furthermore, PET is also reimbursed for non-cancerous diseases 
including myocardial perfusion and viability, dementia, neurodegenerative disease, and pre-
surgical evaluation of patients with refractory seizures. (Evaluations and Pain).  
6.1 Applications in humans  
The staging, preoperative assessment and surgical planning of several human cancers 
realizes theoretical advantages in the use of PET/CT scanning rather than conventional 
imaging with CT. One such cancer is oral/head and neck cancer. In 2010 the American 
Cancer Society estimated that 36,540 cases of cancer of the oral cavity and pharynx would be 
diagnosed among a total of 1,529,560 (2.4%) cancer diagnoses during the same year. (Jemal, 
Siegel et al. 2010)   While most cancers of the oral cavity and pharynx are squamous cell 
carcinomas, and therefore mucosal in origin and readily detectable on self-examination, the 
five year survival rate of such cancers has remained relatively dismal over the past 50 years 
at 50%. Early detection of the primary cancer and regional lymphatic spread to the cervical 
lymph nodes might be a means to improving the survival of patients with this disease. To 
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this end, clinical examination of at risk patients and anatomic imaging with ultrasound 
(Gor, Langer et al. 2006), computed tomography (Coughlin and Resto 2010), or magnetic 
resonance imaging (Coughlin and Resto 2010) could possibly represent a means for early 
detection of cancer of the oral cavity and pharynx, and their regional lymph nodes, thereby 
leading to more expedient treatment of these cancers with the possibility of a more favorable 
prognosis. In oncologic terms, a patient with no signs of cervical lymph node involvement is 
labeled N0, while the patient with palpable cervical lymph node disease is labeled N+. The 
designation of the neck in the TNM classification (tumor size, neck lymph nodes, metastasis) 
represents one of the more important aspects of staging of patients with cancer of the oral 
cavity and pharynx. Specifically, the removal of cervical lymph nodes that identify occult 
histologic disease has survival benefits to patients, rather than adopting the wait and watch 
approach to the cervical lymph nodes and resorting to a neck dissection only when clinically 
palpable lymph nodes are present. Studies have been carried out regarding the imaging 
criteria that would permit prediction of metastatic disease in the cervical lymph nodes, 
particularly those that are equivocal in their size and clinical character. Nonetheless, most 
studies have shown that imaging studies are of limited value for the accurate staging of 
cervical lymph nodes. (van den Brekel 2000)  Owing to the anatomic and physiologic 
assessment inherent in PET/CT scanning, investigators have looked towards this modality of 
imaging to determine if increased sensitivity and specificity can be realized when applying 
this technology to the assessment of the cervical lymph nodes in patients with oral cavity 
cancers. Such reports have shown that PET/CT is effective for the diagnosis, staging, and 
restaging of malignancies of the head and neck region. (Myers, Wax et al. 1998; Blodgett, Fukui 
et al. 2005; Fukui, Blodgett et al. 2005) There was a reported sensitivity of 70-90% and 
specificity of 80-95% for the patients in whom their cervical lymph nodes are determined to be 
clinically positive (N+). (Mukherji and Bradford 2006)  
In 2007 our molecular imaging research center investigated the role of 18F-FDG PET/CT in 
the preoperative prediction of the presence and extent of neck disease in patients with 
oral/head and neck cancer. (Nahmias, Carlson et al. 2007)  Seventy patients were enrolled in 
the study, 47 of whom had a clinically negative neck (N0), 19 of whom had a clinically 
positive unilateral neck (N+), and 4 of whom had a negative neck on one side and positive 
on the other. Each patient underwent a PET/CT study prior to undergoing selective neck 
dissection for N0 disease or modified radical neck dissection for N+ disease. Eighty-three 
neck dissections were performed in the 70 patients. The neck dissections were oriented as to 
oncologic levels for the pathologist processing and interpreting the tissues so as to permit 
correlation between histopathologic findings and the imaging results. One hundred ninety-
two (11.4%) of the 1,678 lymph nodes recovered were histologically positive for metastatic 
disease. The sensitivity and specificity of the PET/CT procedure were 79% and 82% for the N0 
neck, and 95% and 25% for the N+ neck. In patients with clinically negative necks, therefore, a 
negative PET/CT result would not help the oncologic surgeon in the management of the 
patient due to the rate of false-negative results, but a positive PET/CT result can diagnose 
metastatic deposits with a high positive predictive value. In patients with clinically positive 
necks, a positive test will confirm the presence of disease, although false-negative lymph 
nodes were additionally identified in these clinically positive necks. With respect to the lymph 
nodes, the sensitivity of the imaging procedure is such that the results could not assist the 
surgeon in deciding whether the patients with N0 necks benefit by a prophylactic neck 
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dissection. This realization reinforces the 21st century practice of prophylactic neck dissections 
in patients with N0 staging associated with cancer of the oral cavity. 
In 2009 our molecular imaging research center investigated the use of PET/CT in patients 
with oral/head and neck cancer with an assessment of the cervical lymph nodes according 
to time points. In this study, patients underwent a dynamic PET/CT scan consisting of nine 
time points over 60-115 minutes post-injection. Sixty patients underwent 64 neck dissections 
whereby 2,170 lymph nodes were evaluated by a static 90 minute study and 118 lymph 
nodes were studied by time points. A mean SUV (standard uptake value) of hypermetabolic 
lymph nodes was plotted as a function of time. A lymph node with greater than 10% change 
was designated as metastatic. The time point data showed a sensitivity and specificity of 
58% and 71% respectively.  
6.2 Applications in animals  
PET/CT is considered novel as a diagnostic technique in clinical veterinary medicine 
although its use in live animal research endeavors is well recognized. Lack of available 
equipment and high cost of PET radiopharmaceuticals have limited the use of PET as a 
clinical diagnostic tool in veterinary medicine, and the few reports available to date have 
focused on 18FDG PET and PET/CT in veterinary oncology. (Page, Garg et al. 1994; 
Matwichuk, Daniel et al. 1999; Bassett, Daniel et al. 2002; Bruehlmeier, Kaser Hotz et al. 
2005; Ballegeer, Forrest et al. 2006; LeBlanc, Jakoby et al. 2009) Currently, the availability of 
PET for staging and evaluation of response to therapy in clinical veterinary patients is 
limited to a few locations in the United States. Applications in veterinary oncology will 
increase as this technology becomes more widely available, aided considerably by regional 
cyclotron distribution networks for radiopharmaceutical sales. 
Both dogs and cats have been used in research settings for novel PET tracer validation 
studies for many years as their physical size permits serial blood sampling and in vivo 
imaging procedures, in addition to their comparable metabolic and physiologic 
characteristics. (Larson, Weiden et al. 1981; Larson, Weiden et al. 1981; Page, Garg et al. 
1994; Cook, Carnes et al. 2007) To date, the majority of radiopharmaceuticals employed for 
clinical PET in companion animals are commercially available 18F-labelled molecules such as 
18FDG and 18FLT. The majority of these studies have been performed in animals with known 
or suspected malignancies for the purposes of lesion characterization, tumor staging or for 
monitoring response to anticancer therapy.  
Special considerations for veterinary species undergoing PET/CT imaging center on the 
necessary use of general anesthesia for patient positioning and immobilization for 
scanning procedures. PET/CT scans, similar to other cross-sectional imaging techniques 
such as CT or MRI, are uniformly performed with widely used sedative and anesthetic 
drugs in veterinary patients. Risks associated with general anesthesia may preclude the 
use of this diagnostic technique in sick or debilitated animals. There are no standardized 
recommendations regarding 18FDG dose, but ranges of 0.1 - 0.2 mCi per kg body weight 
have been reported. (LeBlanc, Jakoby et al. 2008; Lawrence, Vanderhoek et al. 2009; 
LeBlanc, Jakoby et al. 2009; LeBlanc, Wall et al. 2009) Veterinary patients require 12 hours’ 
fast and use of sedative premedications with cage confinement after 18FDG injection to 
minimize aberrant uptake of 18FDG in skeletal muscle during the tracer uptake period. 
Some imaging sites also use general anesthesia for the tracer uptake period for radiation 
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safety considerations, as it is difficult to control spontaneous urination and/or defecation 
of radioactive waste in companion animals. Following the tracer uptake period, animals 
are placed under general anesthesia and the CT and PET data collected as for a human 
patient scan. (LeBlanc, Jakoby et al. 2008; LeBlanc, Jakoby et al. 2009; LeBlanc, Wall et al. 
2009) 
Reports of clinical PET and PET/CT in companion animals are sparse in the veterinary 
literature. Recent studies of whole-body PET and PET/CT in normal dogs and cats 
demonstrate patterns of 18FDG distribution and SUVs for parenchymal organs to assist in 
lesion interpretation in disease states. (LeBlanc, Jakoby et al. 2008; LeBlanc, Wall et al. 2009) 
A recent investigation of whole-body PET as a staging tool demonstrated the avidity of 
canine cutaneous mast cell tumor and lymphoma for 18FDG. (LeBlanc, Jakoby et al. 2009) 
Newer studies have documented 18FDG uptake using PET/CT fusion in specific 
malignancies, inflammatory brain disease, and have investigated the impact of different 
anesthesia protocols on physiologic brain uptake of 18FDG. (Lee, Lee et al. ; Lawrence, 
Vanderhoek et al. 2009; Kang, Kim et al. 2010; Lee, Lee et al. 2010; Lee, Ko et al. 2010) 
As studies are published that fully validate its use as a non-invasive whole-body staging 
method, PET using commercially-available tracers will become a useful and innovative 
tool in the management of veterinary patients. From a research perspective, companion 
animals represent robust and relevant models for the validation of new PET tracers in a 
variety of diseases that affect both humans and animals alike. (Lawrence, Rohren et al. 
2010)  
7. PET/CT: Today and tomorrow 
Although a fairly young tool, PET/CT is already irreplaceable in many applications, and 
the continued improvement of scanner performance promises further clinical integration. 
However, its full potential remains unrealized largely due to the relative limited 
availability of useful radiotracers. As new tracers are developed and scanning protocols 
are further refined, the trend in patient care will become more personalized and tailored 
to specific disease, ultimately allowing doctors to provide the best possible care for their 
patients. 
8. References 
Bailey, D. and S. Meikle (1994). "A convolution-subtraction scatter correction method for 3D 
PET." Physics in Medicine and Biology 39: 411. 
Ballegeer, E. A., L. J. Forrest, et al. (2006). "PET/CT Following Intensity Modulated 
Radiation Therapy for Primary Lung Tumor in a Dog." Veterinary Radiology & 
Ultrasound 47(2): 228-233. 
Barney, J., J. Rogers, et al. (1991). "Object shape dependent scatter simulations for PET." 
Nuclear Science, IEEE Transactions on 38(2): 719-725. 
Barrett, H. H. and K. J. Myers (2004). Foundations of image science. Hoboken, NJ, Wiley. 
Bassett, C. L. M., G. B. Daniel, et al. (2002). "Characterization of Uptake of 2-Deoxy-2-
[18F] Fluoro-D-Glucose by Fungal-Associated Inflammation:: The Standardized 
Uptake Value is Greater for Lesions of Blastomycosis than for Lymphoma in 
www.intechopen.com
 
PET/CT 
 
65 
Dogs with Naturally Occurring Disease." Molecular Imaging & Biology 4(3): 
201-207. 
Bergström, M., L. Eriksson, et al. (1983). "Correction for scattered radiation in a ring detector 
positron camera by integral transformation of the projections." Journal of Computer 
Assisted Tomography 7(1): 42. 
Beyer, T., P. Kinahan, et al. (1994). The use of X-ray CT for attenuation correction of PET 
data, IEEE. 
Bietendorf, J. (2004). "FDG PET Reimbursement." Journal of Nuclear Medicine Technology 
32(1): 33. 
Blodgett, T. M., M. B. Fukui, et al. (2005). "Combined PET-CT in the Head and Neck." 
Radiographics 25(4): 897. 
Bruehlmeier, M., B. Kaser Hotz, et al. (2005). "Measurement of tumor hypoxia in 
spontaneous canine sarcomas." Veterinary Radiology & Ultrasound 46(4): 348-
354. 
Carson, R., M. Daube-Witherspoon, et al. (1988). "A method for postinjection PET 
transmission measurements with a rotating source." Journal of Nuclear Medicine 
29(9): 1558. 
Casey, M. and R. Nutt (1986). "A multicrystal two dimensional BGO detector system for 
positron emission tomography." IEEE Trans. Nucl. Sci 33(1): 460-463. 
Cherry, S., M. Dahlbom, et al. (1991). "3D PET using a conventional multislice tomograph 
without septa." Journal of Computer Assisted Tomography 15(4): 655. 
Cook, R. A. H., G. Carnes, et al. (2007). "Respiration-averaged CT for attenuation correction 
in canine cardiac PET/CT." Journal of Nuclear Medicine 48(5): 811. 
Coughlin, A. and V. A. Resto (2010). "Oral Cavity Squamous Cell Carcinoma and the 
Clinically N0 Neck: The Past, Present, and Future of Sentinel Lymph Node Biopsy." 
Current oncology reports 12(2): 129-135. 
Evaluations, A. P. and P. O. Pain "Medicare National Coverage Determinations Manual." 
Fukui, M. B., T. M. Blodgett, et al. (2005). "Combined PET-CT in the Head and Neck." 
Radiographics 25(4): 913. 
Gindi, G., M. Lee, et al. (1991). Bayesian reconstruction of functional images using registered 
anatomical images as priors, Springer. 
Gor, D. M., J. E. Langer, et al. (2006). "Imaging of cervical lymph nodes in head and neck 
cancer: the basics." Radiologic Clinics of North America 44(1): 101-110. 
Grootoonk, S., T. Spinks, et al. (1996). "Correction for scatter in 3D brain PET using a dual 
energy window method." Physics in Medicine and Biology 41: 2757. 
Hubbell, J. and U. S. N. B. o. Standards (1969). Photon cross sections, attenuation 
coefficients, and energy absorption coefficients from 10 keV to 100 GeV, US 
National Bureau of Standards; for sale by the Supt. of Docs., US Govt. Print. 
Off. 
Jakoby, B., Y. Bercier, et al. "Performance investigation of a time-of-flight PET/CT 
scanner." 
Jemal, A., R. Siegel, et al. (2010). "Cancer statistics, 2010." CA: A Cancer Journal for 
Clinicians: caac. 20073v20071. 
www.intechopen.com
 
CT Scanning – Techniques and Applications 
 
66
Kang, B. T., S. G. Kim, et al. (2010). "Correlation between fluorodeoxyglucose positron 
emission tomography and magnetic resonance imaging findings of non-
suppurative meningoencephalitis in 5 dogs." The Canadian Veterinary Journal 
51(9): 986. 
Kinahan, P., D. Townsend, et al. (1998). "Attenuation correction for a combined 3D PET/CT 
scanner." Medical Physics 25: 2046. 
Kluetz, P., C. Meltzer, et al. (2000). "Combined PET/CT Imaging in Oncology:: Impact on 
Patient Management." Clinical Positron Imaging 3(6): 223-230. 
Larson, S. M., P. L. Weiden, et al. (1981). "Positron Imaging Feasibility Studies. II: 
Characteristics of 2-Deoxyglucose Uptake in Rodent and Canine Neoplasms: 
Concise Communication." J Nucl Med 22(10): 875-879. 
Larson, S. M., P. L. Weiden, et al. (1981). "Positron Imaging Feasibility Studies. I: 
Characteristics of [3H]Thymidine Uptake in Rodent and Canine Neoplasms: 
Concise Communication." J Nucl Med 22(10): 869-874. 
Lawrence, J., E. Rohren, et al. (2010). "PET/CT today and tomorrow in veterinary cancer 
diagnosis and monitoring: fundamentals, early results and future perspectives." 
Veterinary and Comparative Oncology 8(3): 163-187. 
Lawrence, J., M. Vanderhoek, et al. (2009). "Use of 3-Deoxy-3-[18F]Fluorothymadine 
PET/CT for Evaluating Response to Cytotoxic Chemotherapy in Dogs with 
Non Hodgkin's Lymphoma." Veterinary Radiology & Ultrasound 50(6): 660-
668. 
LeBlanc, A. K., B. Jakoby, et al. (2008). "Thoracic and Abdominal Organ Uptake of 2-Deoxy-
2-[18F]Fluoro-D-Glucose (18FDG) with Positron Emission Tomography in the 
Normal Dog." Veterinary Radiology & Ultrasound 49(2): 182-188. 
LeBlanc, A. K., B. W. Jakoby, et al. (2009). "[18F]FDG PET Imaging in Canine Lymphoma 
and Cutaneous Mast Cell Tumor." Veterinary Radiology & Ultrasound 50(2): 215-
223. 
LeBlanc, A. K., J. S. Wall, et al. (2009). "Normal Thoracic and Abdominal Distribution of 2-
Deoxy-2-[18F]Fluoro-D-Glucose (18FDG) in Adult Cats." Veterinary Radiology & 
Ultrasound 50(4): 436-441. 
Lee, A., M. Lee, et al. (2010). "Imaging Diagnosis-FDG PET/CT of a Canine Splenic Plasma 
Cell Tumor." Veterinary Radiology & Ultrasound 51(2): 145-147. 
Lee, M., J. Ko, et al. (2010). "Effects of Anesthetic Protocol on Normal Canine Brain Uptake 
of 18F-FDG Assessed by PET/CT." Veterinary Radiology & Ultrasound 51(2): 130-
135. 
Lee, M., A. Lee, et al. "Characterization of Physiologic 18F-FDG Uptake with PET/CT in 
Dogs." Veterinary Radiology & Ultrasound. 
Matwichuk, C. L., G. B. Daniel, et al. (1999). "Fluorine-18 Fluorodeoxyglucose Accumulation 
in Blastomyces dermatitidis-Associated Inflammation in a Dog* 1." Clinical 
Positron Imaging 2(4): 217-221. 
Mukherji, S. K. and C. R. Bradford (2006). "Controversies: Is There a Role for Positron-
Emission Tomographic CT in the Initial Staging of Head and Neck Squamous Cell 
Carcinoma?" American Journal of Neuroradiology 27(2): 243. 
www.intechopen.com
 
PET/CT 
 
67 
Mumcuoglu, E., R. Leahy, et al. (1996). "Bayesian reconstruction of PET images: 
methodology and performance analysis." Physics in Medicine and Biology 41: 
1777. 
Myers, L. L., M. K. Wax, et al. (1998). "Positron Emission Tomography in the Evaluation of 
the N0 Neck." The Laryngoscope 108(2): 232-236. 
Nahmias, C., E. Carlson, et al. (2007). "Positron Emission Tomography/Computerized 
Tomography (PET/CT) Scanning for Preoperative Staging of Patients With 
Oral/Head and Neck Cancer." Journal of Oral and Maxillofacial Surgery 65(12): 
2524-2535. 
Ollinger, J. (1996). "Model-based scatter correction for fully 3D PET." Physics in Medicine 
and Biology 41: 153. 
Page, R. L., P. K. Garg, et al. (1994). "PET imaging of osteosarcoma in dogs using a fluorine-
18-labeled monoclonal antibody Fab fragment." Journal of Nuclear Medicine 35(9): 
1506. 
Pelizzari, C., G. Chen, et al. (1989). "Accurate three-dimensional registration of CT, PET, 
and/or MR images of the brain." Journal of Computer Assisted Tomography 13(1): 
20. 
Phelps, M., E. Hoffman, et al. (1976). "Tomographic images of blood pool and perfusion in 
brain and heart." Journal of Nuclear Medicine 17(7): 603. 
Phelps, M., E. Hoffman, et al. (1975). "Application of annihilation coincidence detection 
to transaxial reconstruction tomography." Journal of Nuclear Medicine 16(3): 
210. 
Pietrzyk, U., K. Herholz, et al. (1996). "Clinical applications of registration and fusion of 
multimodality brain images from PET, SPECT, CT, and MRI*." European journal of 
radiology 21(3): 174-182. 
Shapiro, J. (2002). Radiation protection : a guide for scientists, regulators, and physicians. 
Cambridge, Mass. [u.a.], Harvard University Press. 
Shreve, P. and D. W. Townsend (2008). Clinical PET-CT. New York; London, Springer. 
Stearns, C. (1995). "Scatter correction method for 3D PET using 2D fitted Gaussian 
functions." J Nucl Med 36: 105. 
Townsend, D., T. Beyer, et al. (2003). PET/CT scanners: a hardware approach to image 
fusion, Elsevier. 
Townsend, D., T. Beyer, et al. (1998). The SMART scanner: a combined PET/CT tomograph 
for clinical oncology, IEEE. 
Valk, P. E. (2003). Positron emission tomography : basic science and clinical practice. 
London; New York, Springer. 
van den Brekel, M. W. M. (2000). "Lymph node metastases: CT and MRI." European journal 
of radiology 33(3): 230-238. 
Warburg, O., K. Posener, et al. (1931). "The metabolism of the carcinoma cell." The 
Mechanism of Tumors: 129–169. 
Watson, C. (2000). "New, faster, image-based scatter correction for 3D PET." Nuclear 
Science, IEEE Transactions on 47(4): 1587-1594. 
www.intechopen.com
 
CT Scanning – Techniques and Applications 
 
68
Watson, C., D. Newport, et al. (1996). "A single scatter simulation technique for scatter 
correction in 3D PET." Three-Dimensional Image Reconstruction in Radiology and 
Nuclear Medicine 4: 255–268. 
Workman, R. and R. Coleman (2006). PET/CT essentials for clinical practice, Springer. 
www.intechopen.com
CT Scanning - Techniques and Applications
Edited by Dr. Karupppasamy Subburaj
ISBN 978-953-307-943-1
Hard cover, 348 pages
Publisher InTech
Published online 30, September, 2011
Published in print edition September, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Since its introduction in 1972, X-ray computed tomography (CT) has evolved into an essential diagnostic
imaging tool for a continually increasing variety of clinical applications. The goal of this book was not simply to
summarize currently available CT imaging techniques but also to provide clinical perspectives, advances in
hybrid technologies, new applications other than medicine and an outlook on future developments. Major
experts in this growing field contributed to this book, which is geared to radiologists, orthopedic surgeons,
engineers, and clinical and basic researchers. We believe that CT scanning is an effective and essential tools
in treatment planning, basic understanding of physiology, and and tackling the ever-increasing challenge of
diagnosis in our society.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Joshua D. Schaefferkoetter, Eric R. Carlson and Amy K. LeBlanc (2011). PET/CT, CT Scanning - Techniques
and Applications, Dr. Karupppasamy Subburaj (Ed.), ISBN: 978-953-307-943-1, InTech, Available from:
http://www.intechopen.com/books/ct-scanning-techniques-and-applications/pet-ct
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
